Syngenta Lawsuits Settled for $1.4 Billion to U.S. Corn Industry

September 27, 2017

Swiss based Agri-giant Syngenta (with revenues of over $12 Billion USD in 2016) yesterday agreed to settle all claims of U.S. corn farmers, along with claims of grain elevator owners and ethanol producers.  Syntenta will pay about $1.4 Billion, representing approximately the same amount as it earned as profits in 2016.  Terms are confidential; however, the settlement would establish a fund to pay claims by farmers who contracted to price corn or corn byproducts after Sept. 14, 2013. Details will be announced after the agreement is submitted for court approval later this year.

In 2010, Syngenta announced that it planned to commercialize a new hybrid corn seed under the trade name Agrisure® Viptera™. Although Viptera had been approved by the USDA, it was not approved by our major export markets, most notably China. At the time, it was clear that China was a large and rapidly growing market for U.S. corn. As a result, several national trade organizations, including the NGFA and NAEGA, sent a very public letter to Syngenta asking it not to commercialize Viptera until it was approved for import into China. Syngenta was told in no uncertain terms that it was risking the U.S. corn trade market—and thus U.S. corn prices.

“Putting the Chinese and other markets at risk with such aggressive commercialization of biotech-enhanced events is not in the best interest of U.S. agriculture or the U.S. economy.” Joint Statement by National Grain and Feed Association and North American Export Grain Association CLICK HERE to read the full statement.

Despite the warnings, Syngenta nevertheless proceeded to broadly commercialize Viptera.

Understanding the potential harm to corn prices, one of the top 3 grain elevators, Bunge, put up signs saying it was not going to purchase Viptera corn. In response, Syngenta sued Bunge in federal court, asking the court to order Bunge to purchase Viptera corn. Syngenta argued that Bunge could simply segregate Viptera corn to prevent it from contaminating corn that would be shipped overseas. The court denied Syngenta’s request and found that it was unreasonable to ask grain elevators to segregate Syngenta’s corn—and the cost would be astronomical.

As predicted, Viptera contaminated the U.S. corn supply. In November 2013, China, then the second largest importer of U.S. corn, found Viptera in a shipment of corn during inspection. At the time, China had not approved Viptera and turned the ship around at the dock. During inspections in late 2013 and early 2014, China discovered that many shipments of U.S. corn were contaminated with the Viptera GMO trait. In response, China banned the import of all U.S. corn. Not surprisingly, corn prices have fallen and studies conducted by the NGFA and the NAEGA have found that Syngenta’s conduct has caused billions of dollars of harm to corn farmers and the entire U.S. corn supply channel.

The trade organizations again sent letters to Syngenta asking it to pull Viptera from the market until it obtained China’s approval.

“NAEGA and NGFA are gravely concerned about the serious economic harm to exporters, grain handlers and, ultimately, agricultural producers – as well as the United States’ reputation to meet its customers’ needs – that has resulted from Syngenta’s current approach to stewardship of Viptera. Further, the same concerns now transcend to Syngenta’s intended product launch plans for Duracade, which risk repeating and extending the damage. Immediate action is required by Syngenta to halt such damage.” NGFA and NAEGA Joint Statement

Our expert economists have calculated that farmers lost 50 cents per bushel of corn in that first year after the ban; after that, our experts have calculated an additional 15 cents per bushel through today.

Some of the big exporters, including Cargill, ADM, and Trans Coastal, have filed lawsuits against Syngenta. Shortly after China imposed its ban on U.S. corn, trade groups estimated the total losses at around $3 billion and predicted (accurately) that the decline in corn prices would continue.

Syngenta Litigation

Case Update:

September 26, 2017: The second class trial was stopped and settled in Minneapolis, and Syngenta agreed to pay about $1.4 Billion to fund the compensate farmers, grain elevator operators and ethanol producers.

July 5, 2017: The first trial on behalf of an individual farmer was set to begin on July 10, 2017. Just before the Final Pretrial Conference, the parties agreed to a confidential settlement in this individual farmer’s case. The next trial will begin on September 11, 2017 and is on behalf of a class of Minnesota corn farmers.

June 23, 2017: The first class trial occurred in June 2017. On June 23, 2017, the jury returned a unanimous verdict for Plaintiffs, which were a group of 7,343 Kansas farmers. The jury awarded full damages in the amount of $217,700,000 ($217.7 Million). You can read more about the farmer’s win here:

Notice to Corn Farmers and Silo Owners:  It is not too late to join in the litigation if you have been harmed.  Farmers and others who ‘opt out’ of the Class Action will be considered for substantially greater (full compensation) damages.  Please contact Avery Law Firm at toll free 866-987-4368 or complete the contact form below:

Contact us to begin your Free Confidential Case Evaluation now!
* indicates required field


Patient Complaint filed in San Diego California against Scripps Health d/b/a Green Hospital

A copy of the Complaint filed in San Diego Superior Court, captioned Jose Vidrio v. Scripps Health can be found here:  HCA California Complaint 4 -28-16


4/28/2016 4:14:40 PM CST


            Re: Town Hall Meeting (04/29/16) Re Patient Lawsuit Against Scripps Green Hospital


La Jolla, CA- AVERY LAW FIRM (Denver, CO), PAUL McINNES LLP (Kansas City, MO) and HILLYARD WAHLBERG KUDLA SLOANE & WOODRUFF LLP (Denver, CO) will host a Town Hall meeting to discuss the patient lawsuit against Scripps Green Hospital (La Jolla, CA), based on the patients suffering extreme emotional distress and bodily injury as a result of exposure to HIV, Hepatitis B and Hepatitis C as a result of the reckless hiring of convicted drug abuser Rocky Allen as a surgical technologist to work in the O.R. after he was court-martialed in 2011.  Allen was indicted a second time in February on federal drug charges in Denver. According to Federal prosecutors in Denver, Allen has tested positive for “bloodborne pathogens.”  No further information has been released. Scripps has sent a letter to the patients exposed to get tested for HIV, Hepatitis B and C.


Before his hiring at Scripps Green Hospital, Allen had been discharged from the Navy where he was court-martialed and admitted stealing and possessing Fentanyl with intent to use it on himself while on duty in Afghanistan.  A public affairs officer of the Office of the Judge Advocate General of the Navy was reported in the Denver Post on February 26, 2016 as saying a telephone call from a hospital to the Navy’s personnel command inquiring about Allen’s military service would have revealed the court martial. 


Similar claims are pending against other hospitals: Swedish Medical Center (CO), Northwest Hospital (WA), Banner Thunderbird and HonorHealth John C. Lincoln Medical Centers (AZ). Approximately 5,000 patients are suspected of being exposed to infection as a result of the employment in the five hospitals. 


Jim Avery will conduct the Town Hall meeting on Friday, April 29, 2016 from 6-9PM at the San Diego Marriott La Jolla, 4240 La Jolla Village Drive, San Diego, CA  92037 in the Pacific Beach Room to explain the details of the case to the public. Visit or for additional information.


Contacts for further information:

Denver-Attorney Jim Avery/Avery Law Firm:  303-840-2222

Kansas City – Attorney Rick Paul/Paul McInnes LLP:  855-984-8100

Denver – Attorney Dan Sloane/Denver Trial Lawyers: 303-571-5302

If you or a loved one has been affected by this atrocity, please feel free to contact Jim Avery or fill out the contact form below:

Comments or questions are welcomed.